FREDERICK, Md., Oct. 11, 2012 /PRNewswire/ -- BioElectronics Corporation (BIEL: OTCPK), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President, was featured on 'The Stocks and Jocks Radio' show to describe the Company's rapid international expansion, its US FDA market clearance progress, recent published medical journal articles, new clinical studies, and the availability of ActiPatch® on Amazon.co.uk in Europe, where its customer's product satisfaction is 97%.
Mr. Whelan described BioElectronics' international sales and marketing strategy that recruited 10 new distributors covering 16 countries in recent weeks. He contributed the success to the new marketing campaigns and the recent Consumer Survey indicating that the ActiPatch, topical musculoskeletal therapy is 5x better pain relief,100% safer than over-the-counter drugs, and cost less than twenty-five cents for each 8-hour therapy session, a fraction of the cost of competitive therapies. Mr. Whelan expressed his delight that the products were selling well in Europe, which is twice the market size of the US covering 214,000 pharmacies and doing in excess 34+ billion in Euros in over-the-counter medications.
About Stocks and Jocks
"'Stocks and Jocks' combines the market insight of Louis Rukeyeser, a dash of sports, and the humor of Seinfeld with truly honest stock market advice." In the interview with financial guru Tom Haugh Mr. Whelan discusses the development of BIEL's products, why they are useful in reducing swelling and accelerating healing, and how they can be used to alleviate back pain, an ankle sprain, or to help heal a chronic wound.
About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and accelerate healing. For more information, please visit www.bielcorp.com.
SOURCE BioElectronics Corporation